department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Accutar Biotechnology Inc · pharmadog

PUBLIC COMPANY

Accutar Biotechnology Inc

updated 1mo ago

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

2Phase 1

Diffuse Large B-Cell Lymphoma

Human Epidermal Growth Factor Receptor 2 Negative Breast…

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Accutar Biotechnology Inc jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

Oncology2 DLBCL1

mentioned in

0news items

entity-linker matched

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase1A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignanciesrecruitingn=60
phase1Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Canceractive not recruitingn=100
phase1A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancerterminatedn=28
phase1A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancerterminatedn=21
phase1A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancerterminatedn=8
phase1A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancerterminatedn=6